Trials / Sponsors / Impel Pharmaceuticals
Impel Pharmaceuticals
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | INP105 Proof-of-concept Study for the Acute Treatment of Agitation in Adolescents and Young Adults With ASD Agitation in Adolescents and Young Adults With ASD | Phase 2 | 2022-06-23 |
| Completed | Safety and Tolerability of INP105 (Olanzapine by I231 POD® Device) Nasal Spray in Healthy Volunteers - SNAP 10 Acute Agitation | Phase 1 | 2018-08-05 |
| Completed | Safety and Tolerability of POD-DHE (INP104) in Migraine (STOP 301) Migraine Headache | Phase 3 | 2018-07-13 |
| Completed | Therapeutic Potential for Intranasal Levodopa in Parkinson's Disease -Off Reversal Parkinson's Disease | Phase 2 | 2018-05-08 |
| Completed | Bioavailability of DHE Administered by I123 POD Device, IV Injection, and Migranal Nasal Spray in Healthy Adul Migraine Headache | Phase 1 | 2017-10-19 |